Strong data hygiene, formal governance, and human oversight are becoming essential to responsible, scalable AI adoption in clinical trials.
- From 73% Noncompliant To 2.4%: Building A Compliance Office
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Token Costs Will Decide Clinical Supply AI
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Streamlined Site Study Start-Up
Explore the critical process of Study Start-Up (SSU) in clinical trials, with an emphasis on the collaborative efforts of sponsors and research sites to enhance efficiency and reduce timelines.
-
Inova Health System Uses Advarra eReg Workflows And Integrations To Improve Regulatory Efficiency
Maintaining efficient, effective regulatory management processes can be a significant challenge. At Inova Health System, the research team improved regulatory efficiency by 20% without the need for extra regulatory staff by adopting Advarra’s eRegulatory Management System.
-
Virtual eConsent For Decentralized Trials
Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.
-
Could ePRO Be The New Standard In Health Reimbursement?
Recently, early-phase protocols have been collecting patient-reported outcomes (PROs) not only to get regulatory approval but to demonstrate value to public and private payers.
-
Achieving Faster, Simpler Validation Through Crowdsource UAT
An approach most often seen in the larger tech space, crowdsource UAT can offer several potential advantages for the clinical trial industry and eTMF validation.
-
Simplify Clinical Trials With Signant SmartSignals® Unified Platform
Signant SmartSignals® Unified Platform streamlines clinical trials by integrating eConsent, data collection, remote consultations, and randomization, simplifying workflows for patients and site staff.
-
Why Trial Expertise Makes Or Breaks Clinical AI
What makes AI effective in clinical trials? See how a top 5 pharma sponsor achieved a 62% reduction in CRA task time and 99% document classification accuracy by prioritizing clinical fluency.
-
Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation Study
This study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.
-
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers
Explore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
Preparing Studies With eConsent For IRB Approval
Understand how eConsent can benefit trials and align with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models.
RECENT NEWSLETTERS
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks